Search - tctmd.com

Displaying 1 - 20 of 67

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

Presentation EuroPCR 2024

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

Presenter: Alexandre Abizaid

May 14, 2024

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Conference News EuroPCR 2022

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Caitlin E. Cox

May 25, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

News Conference News EuroPCR 2021

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Caitlin E. Cox

May 24, 2021

News Conference News EuroPCR 2021

Transradial PCI Bests Femoral Access in Complex Cases: COLOR

Michael O'Riordan

May 21, 2021

News Conference News EuroPCR 2021

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

L.A. McKeown

May 21, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Conference News EuroPCR 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

L.A. McKeown

May 19, 2021

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News EuroPCR 2019

EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal

L.A. McKeown

May 23, 2019

News Conference News EuroPCR 2019

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

Caitlin E. Cox

May 23, 2019

News Conference News EuroPCR 2019

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

L.A. McKeown

May 22, 2019

News Conference News EuroPCR 2019

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Caitlin E. Cox

May 21, 2019

Advertisement

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Transradial PCI Bests Femoral Access in Complex Cases: COLOR

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

BASKET-SMALL 2 Angiographic Substudy Supports Safety of DCBs in Small Coronary Vessels

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content